TPTX insider trading
Turning Point Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
TPTX insider activity at a glance
FilingIQ has scored 334 insider transactions for TPTX since Apr 22, 2019. The most recent filing in our index is dated Aug 17, 2022.
Across the full history, 16 open-market purchases
and 252 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TPTX insider trades is 62.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Frequently asked
- How many insider trades does FilingIQ track for TPTX?
- FilingIQ tracks 334 Form 4 insider transactions for TPTX (Turning Point Therapeutics, Inc.), covering filings from Apr 22, 2019 onwards. 0 of those were filed in the last 90 days.
- Are TPTX insiders net buyers or net sellers?
- Across the full Form 4 history for TPTX, 16 transactions (5%) were open-market purchases and 252 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TPTX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
Methodology & sources
Every TPTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.